Paper39137167
Oral resveratrol in adults with knee osteoarthritis: A randomized placebo-controlled trial (ARTHROL).
Nguyen C and 9 others. PLoS Med, 2024. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Oral resveratrol in adults with knee osteoarthritis: A randomized placebo-controlled trial (ARTHROL). Papers, record 39137167. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39137167
- Disease
- osteoarthritis, knee143 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Osteoarthritis, Knee | Major topic |
| Resveratrol | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Double-Blind Method | |
| Administration, Oral | |
| Aged | |
| Treatment Outcome | |
| Pain Measurement | |
| France | |
| Adult |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02905799 | Resveratrol in Knee Osteoarthritis | Results | Yes |
Source ClinicalTrials.gov
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30717015 | French and Mediterranean-style diets: Contradictions, misconceptions and scientific facts-A review. | Food Res Int | 2019 | https://conductscience.org/library/papers/30717015 | PubMed |
| 2 | 18759268 | The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. | Arthritis Rheum | 2008 | https://conductscience.org/library/papers/18759268 | PubMed |
| 3 | 10765924 | Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. | Arthritis Rheum | 2000 | https://conductscience.org/library/papers/10765924 | PubMed |
| 4 | 34174454 | Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data. | Osteoarthritis Cartilage | 2021 | https://conductscience.org/library/papers/34174454 | PubMed |
| 5 | 30233159 | Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: a pilot interventional study. | Clin Interv Aging | 2018 | https://conductscience.org/library/papers/30233159 | PubMed |
| 6 | 18276737 | Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes. | Rheumatology (Oxford) | 2008 | https://conductscience.org/library/papers/18276737 | PubMed |
| 7 | 21484156 | Curcumin synergizes with resveratrol to stimulate the MAPK signaling pathway in human articular chondrocytes in vitro. | Genes Nutr | 2011 | https://conductscience.org/library/papers/21484156 | PubMed |
| 8 | 20924410 | The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. | Nat Rev Rheumatol | 2010 | https://conductscience.org/library/papers/20924410 | PubMed |
| 9 | 19011540 | The action of resveratrol, a phytoestrogen found in grapes, on the intervertebral disc. | Spine (Phila Pa 1976) | 2008 | https://conductscience.org/library/papers/19011540 | PubMed |
| 10 | 18606398 | Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. | Biochem Pharmacol | 2008 | https://conductscience.org/library/papers/18606398 | PubMed |
| 11 | 16632085 | Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable. | J Pain Symptom Manage | 2006 | https://conductscience.org/library/papers/16632085 | PubMed |
| 12 | 24270963 | Body mass index, diabetes, and mortality in French women: explaining away a "paradox". | Epidemiology | 2014 | https://conductscience.org/library/papers/24270963 | PubMed |
| 13 | 31278997 | OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. | Osteoarthritis Cartilage | 2019 | https://conductscience.org/library/papers/31278997 | PubMed |
| 14 | 23328930 | Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway. | Rheumatol Int | 2013 | https://conductscience.org/library/papers/23328930 | PubMed |
| 15 | 33383288 | Pain in women with knee and/or hip osteoarthritis is related to systemic inflammation and to adipose tissue dysfunction: Cross-sectional results of the KHOALA cohort. | Semin Arthritis Rheum | 2021 | https://conductscience.org/library/papers/33383288 | PubMed |
| 16 | 9101522 | Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. | J Rheumatol | 1997 | https://conductscience.org/library/papers/9101522 | PubMed |
| 17 | 20332509 | CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. | BMJ | 2010 | https://conductscience.org/library/papers/20332509 | PubMed |
| 18 | 23376875 | Optimization of trans-Resveratrol bioavailability for human therapy. | Biochimie | 2013 | https://conductscience.org/library/papers/23376875 | PubMed |
| 19 | 9846848 | Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. | Am J Clin Nutr | 1998 | https://conductscience.org/library/papers/9846848 | PubMed |
| 20 | 28350759 | Resveratrol supplementation reduces pain experience by postmenopausal women. | Menopause | 2017 | https://conductscience.org/library/papers/28350759 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942239 | Plant-Derived Polyphenols in Osteoarthritis: Mechanisms, Delivery Systems, and Therapeutic Synergy. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42942239 | PubMed |
| 42941490 | Differential Expression of ACAN, COL1A1, and COL2A1 in Cartilage and Synovium During Osteoarthritis Progression: An Observational Pilot Study Supported by Preliminary Bioinformatic Analysis. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941490 | PubMed |
| 42875481 | Emerging therapies for knee osteoarthritis. | Nat Rev Rheumatol | 2026 | https://conductscience.org/library/papers/42875481 | PubMed |
| 42859207 | Deciphering the mechanisms of resveratrol in knee osteoarthritis treatment: insights from bioinformatics and experimental validation. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42859207 | PubMed |
| 42225637 | Exploring mitochondrial functions and dysfunctions in chondrocytes: toward the identification of novel therapies for osteoarthritis. | Bone Res | 2026 | https://conductscience.org/library/papers/42225637 | PubMed |
| 42018663 | Cyclodextrin-Epichlorohydrin-Cyanoguanidine Polymer for Resveratrol Delivery to Enhance Human Chondrocyte Function in Cartilage Repair. | Biomacromolecules | 2026 | https://conductscience.org/library/papers/42018663 | PubMed |
| 41588481 | Therapeutic Potential of Resveratrol in Cancer and Neurodegenerative Disorders: A Current Review. | Biofactors | 2026 | https://conductscience.org/library/papers/41588481 | PubMed |
| 41037125 | Resveratrol supplementation improves functional performance in knee osteoarthritis by upregulating sirtuin 1: a randomized study. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/41037125 | PubMed |
| 41009494 | Recent Developments in Osteoarthritis Research: Innovative Therapeutic Approaches and the Role of Polyphenols and Nanotechnology. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009494 | PubMed |
| 40995602 | Natural products in the treatment of osteoarthritis: Current status and prospects. | J Orthop Translat | 2025 | https://conductscience.org/library/papers/40995602 | PubMed |
| 40692773 | Pharmacological Mechanisms and Therapeutic Potential of Resveratrol in Rheumatoid Arthritis. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40692773 | PubMed |
| 40502812 | Resveratrol: Molecular Mechanisms, Health Benefits, and Potential Adverse Effects. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40502812 | PubMed |
| 39519419 | Bioactive Compounds and Their Chondroprotective Effects for Osteoarthritis Amelioration: A Focus on Nanotherapeutic Strategies, Epigenetic Modifications, and Gut Microbiota. | Nutrients | 2024 | https://conductscience.org/library/papers/39519419 | PubMed |
| 39519204 | Bioactive Compounds in Osteoarthritis: Molecular Mechanisms and Therapeutic Roles. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39519204 | PubMed |
| 39408977 | Inhibitory Effects of Reynoutria japonica Houtt. on Pain and Cartilage Breakdown in Osteoarthritis Based on Its Multifaceted Anti-Inflammatory Activity: An In Vivo and In Vitro Approach. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39408977 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| RESVERATROL | CHEMBL165 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL165 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39137167
GET https://conductscience.org/api/papers/v1/39137167/references?page=2